Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 4, 2006, Pages 414-421

  Huff, Carol Ann ^a   Fuchs, Ephraim J ^a   Smith, B Douglas ^a   Blackford, Amanda ^a   Garrett Mayer, Elizabeth ^a   Brodsky, Robert A ^a   Flinn, Ian W ^a   Ambinder, Richard F ^a   Borrello, Ivan M ^a   Matsui, William H ^a   Vogelsang, Georgia B ^a   Griffin, Constance A ^a   Luznik, Leo ^a   Jones, Richard J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Allogeneic transplantation; Disease response; Donor lymphocyte infusions; Graft versus host reactions

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 2; TOPOTECAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DEATH; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HISTOCOMPATIBILITY; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PREDICTION; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HEMATOLOGIC NEOPLASMS; HUMANS; LIVING DONORS; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644886960     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.11.520     Document Type: Article

References (38)

1. P.L. Weiden N. Flournoy E.D. Thomas et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med 300 1979 1068-1073
2. P.L. Weiden K.M. Sullivan N. Flournoy R. Storb E.D. Thomas Antileukemic effect of chronic graft-versus-host disease N Engl J Med 304 1981 1529-1533
3. M.M. Horowitz R.P. Gale P.M. Sondel et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555-562
4. H.J. Kolb J. Mittermuller C. Clemm et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462-2465
5. S. Slavin E. Naparstek A. Nagler A. Ackerstein J. Kapelushnik R. Or Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp Hematol 23 1995 1553-1562
6. R.H. Collins Jr O. Shpilberg W.R. Drobyski et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 15 1997 433-444
7. F. Dazzi R.M. Szydlo C. Craddock et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia Blood 95 2000 67-71
8. S. Mackinnon E.B. Papadopoulos M.H. Carabasi L. Reich N.H. Collins R.J. O'Reilly Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: Is T cell dose important in determining biological response? Bone Marrow Transplant 15 1995 591-594
9. R.H. Collins Jr Z.R. Rogers M. Bennett V. Kumar A. Nikein J.W. Fay Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: Apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression Bone Marrow Transplant 10 1992 391-395
10. J. Mehta R. Powles S. Kulkarni J. Treleaven S. Singhal Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: Single-center experience of 32 adult patients Bone Marrow Transplant 20 1997 129-135
11. A.H. Elmaagacli D.W. Beelen G. Trenn O. Schmidt M. Nahler U.W. Schaefer Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation Bone Marrow Transplant 23 1999 771-777
12. H.J. Kolb A. Schattenberg J.M. Goldman et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 86 1995 2041-2050
13. D.L. Porter R.H. Collins Jr C. Hardy et. al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions Blood 95 2000 1214-1221
14. R.H. Collins Jr S. Goldstein S. Giralt et al. Donor leukocyte infusions in acute lymphocytic leukemia Bone Marrow Transplant 26 2000 511-516
15. H.J. Kolb Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties Vox Sang 74 suppl 2 1998 321-329
16. D.L. Porter R.H. Collins Jr O. Shpilberg et al. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions Biol Blood Marrow Transplant 5 1999 253-261
17. L. Luznik E.J. Fuchs Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation Cancer Control 9 2002 123-137
18. E. Alyea E. Weller R. Schlossman et al. T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma induction of graft-versus-myeloma effect Blood 98 2001 934-939
19. M. Salama T. Nevill D. Marcellus et al. Donor leukocyte infusions for multiple myeloma Bone Marrow Transplant 26 2000 1179-1184
20. A. Badros B. Barlogie C. Morris et al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions Blood 97 2001 2574-2579
21. H.M. Lokhorst A. Schattenberg J.J. Cornelissen L.L. Thomas L.F. Verdonck Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation Blood 90 1997 4206-4211
22. D.L. Porter M.S. Roth S.J. Lee C. McGarigle J.L. Ferrara J.H. Antin Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation Bone Marrow Transplant 18 1996 975-980
23. C. Thiede M. Bornhauser U. Oelschlagel et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers Leukemia 15 2001 293-302
24. C. Thiede M. Bornhauser G. Ehninger Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation Acta Haematol 112 2004 16-23
25. V.M. Van Deerlin D.G. Leonard Bone marrow engraftment analysis after allogeneic bone marrow transplantation Clin Lab Med 20 2000 197-225
26. J.J. Sreenan J.D. Pettay A. Tbakhi et al. The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting Am J Clin Pathol 107 1997 292-298
27. B. Crescenzi M. Fizzotti S. Piattoni et al. Interphase FISH for Y chromosome, VNTR polymorphisms, and RT-PCR for BCR-ABL in the monitoring of HLA-matched and mismatched transplants Cancer Genet Cytogenet 120 2000 25-29
28. D. Przepiorka D. Weisdorf P. Martin et al. 1994 Consensus Conference on Acute GVHD Grading Bone Marrow Transplant 15 1995 825-828
29. K. Atkinson M.M. Horowitz R.P. Gale M.B. Lee A.A. Rimm M.M. Bortin Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry Bone Marrow Transplant 4 1989 247-254
30. R.J. Jones C.A. Griffin B.D. Smith et al. GM-CSF-mediated differentiation therapy following bone marrow transplantation (BMT) for chronic myeloid leukemia (CML) [abstract] Blood 90 1997 235a
31. A. Bedi C.A. Griffin J.P. Barber et al. Growth factor-mediated terminal differentiation of chronic myeloid leukemia Cancer Res 54 1994 5535-5538
32. A.L. Petzer C.J. Eaves M.J. Barnett A.C. Eaves Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia Blood 90 1997 64-69
33. R. Bhatia H.A. Munthe A.D. Williams F. Zhang S.J. Forman M.L. Slovak Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation Exp Hematol 28 2000 1401-1412
34. H.M. Lokhorst K. Wu L.F. Verdonck et al. The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma Blood 103 2004 4362-4364
35. F. Dazzi R.M. Szydlo N.C. Cross et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia Blood 96 2000 2712-2716
36. L. Luznik J.E. Slansky S. Jalla et al. Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras Blood 101 2003 1645-1652
37. L. Luznik I. Borrello R. Iannone et al. In vivo priming of donor lymphocyte infusions by tumor vaccines after allogeneic bone marrow transplantation induces potent tumor immunity without lethal GVHD Blood 96 2000 581a
38. L.H. Sehn E.P. Alyea E. Weller et al. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion J Clin Oncol 17 1999 561-568